Medios stock gains 2.23 percent while H1 revenue rises 8.4 percent
Published on 09/26/2026 at 12:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Medios stock (ISIN DE000A1MMCC8) stood at EUR 11.00 on Xetra on September 25, 2026, up 2.23 percent from EUR 10.76. On September 14, 2026, EQS News reported that Chief Business Officer Christoph Prusseit will not extend his management board contract beyond July 31, 2027.
Revenue grows while margins tighten
Medios delivered H1 2026 revenue of EUR 1,074.9 million, an 8.4 percent increase from H1 2025, according to Quartr in its September 14, 2026 company presentation summary. The growth reached all operational segments, but EBITDA pre margin declined to 4.1 percent as price pressure, higher costs and regulatory effects weighed on profitability.
The pressure was sharper in patient-specific therapies. finanzen.net reported on September 2, 2026 that the segment's adjusted EBITDA margin fell to 9.2 percent in H1 2026 from 10.3 percent in H1 2025.
Guidance reset raises the stakes
For 2026, adjusted EBITDA guidance was reduced to EUR 88 million to EUR 92 million from EUR 94 million to EUR 102 million, according to finanzen.net. The change contrasts with the revenue outlook of EUR 2.1 billion to EUR 2.16 billion for the full year, making margin delivery the central operating question.
Medios entered the second half with EUR 200 million of financial debt and almost EUR 525 million of equity as of June 30, 2026, figures also reported by finanzen.net. That balance sheet profile gives the company room to finance expansion, but the 9.2 percent segment margin shows why earnings quality matters alongside sales growth.
Stock stays below last year's level
At EUR 11.00 on September 25, 2026, Medios stock was 26.01 percent below its level one year earlier, according to the SDAX market table. The same Xetra session showed a high of EUR 11.12 and a low of EUR 10.66, with the prior close at EUR 10.76.
Xetra price holds above EUR 10
Medios stock was trading at EUR 11.00 on Xetra on September 25, 2026, after gaining 2.23 percent against the prior close. The market is weighing 8.4 percent H1 revenue growth against the reduced adjusted EBITDA outlook.
Medios stock facts
- Company: Medios AG
- ISIN: DE000A1MMCC8
- WKN: A1MMCC
- Ticker: ILM1
- Trading venue: Xetra
- Price (as of September 25, 2026): EUR 11.00
- Sector / Industry: Healthcare / Medical Distribution
- Index membership: SDAX
